Institutional Development Award

The Institutional Development Award (IDeA) program builds research capacities in states that historically have had low levels of NIH funding by supporting basic, clinical, and translational research; faculty development; and infrastructure improvements. The program also enhances the ability of investigators to compete successfully for additional research funding and serves the research needs of medically underserved communities.

Shaded are the 23 states and territory eligible for IDeA funding.​

IDeA supports faculty development and enhancement of the research infrastructure at institutions located in Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia and Wyoming 

The IDeA program has four main components:

  • Centers of Biomedical Research Excellence (COBRE) augment and strengthen institutional biomedical research capabilities by expanding and developing biomedical faculty research capability through support of a multidisciplinary center led by a peer-reviewed, NIH-funded investigator with expertise central to the theme of the grant proposal.

  • IDeA Networks of Biomedical Research Excellence (INBRE) enhance biomedical research capacity, expand, and strengthen the research capabilities of biomedical faculty, and provide access to biomedical resources for promising undergraduate students throughout the eligible states. INBRE puts the IDeA approach into action by enhancing research infrastructure through support of a statewide research development network that links research-intensive institutions with primarily undergraduate institutions.

  • IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR) provides support for: (1) the development of infrastructure and human resources required to conduct clinical and translational research in IDeA-eligible states, (2) enhancing the ability of IDeA institutions and investigators to develop competitive clinical and translational research programs, (3) fostering and sustaining collaboration and coordination of clinical and translational activities within and across IDeA institutions/ organizations, and (4) addressing health conditions that affect the medically underserved and/or that are prevalent among populations in IDeA states.

  • IDeA Co-funding provides support to NIH investigator-initiated R01 or R15 applications that received excellent ratings through the peer review process, but fell beyond an Institute’s or Center’s (ICs) pay line. NIH ICs select and submit eligible applications to NIGMS for consideration for IDeA Co-funding support, and maintain the administration and management of the applications that receive IDeA Co-funding.

For more information about the IDeA program, contact Dr. Ming Lei​.